Back to ABIVAXInsider 
Company
TRUFFLE CAPITAL SAS — ABIVAX
Filing 2024DD996831Published 24 Sept 2024France public disclosures
InitialEffective
Summary
TRUFFLE CAPITAL SAS
Philippe Pouletty, Membre du conseil d'administration
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€350,000.00
Net buy/sell
-€350,000.00
Other reported value
€0.00
Gross reported value
€350,000.00
Transactions
1
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 18 Sept 2024 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 35,000 | €10.00 | €350,000.00 | XPAR |
Sell
Execution date18 Sept 2024Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 35,000
- Unit price
- €10.00
- Total
- €350,000.00
Evidence
- AMF · France2024DD996831
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.